CIK 0001768446 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Climb Bio, Inc.
Sign in to watch- Ticker
- CLYM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 832273741
- Phone
- 1-866-857-2596
- Business address
- 20 WILLIAM STREET, SUITE G50, WELLESLEY HILLS, MA
- Former names
- Eliem Therapeutics, Inc.
- 4 Planned sale Director sold 100,000 shares at an average $5.29 ($529,129)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market buy Director bought 7,111 shares at $3.50 ($24,889)
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy Director bought 314,561 shares at an average $2.40 ($754,737)
- 8-K Event Material agreement · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- SCHEDULE 13D/A Stake Beneficial Ownership Report
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
Page 4 of 17 · 326 filings